AeroLeads people directory · profile

David S. Email & Phone Number

Location: San Francisco Bay Area, United States, United States 8 work roles 3 schools
LinkedIn matched
✓ Verified May 2026 3 data sources Profile completeness 57%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Location
San Francisco Bay Area, United States, United States

Who is David S.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

AeroLeads shows a matched LinkedIn profile for David S..

David S. previously worked as Research Fellow at Vir Biotechnology Inc. and DMPK consultant at Vir Biotechnology And Rigel Pharmaceuticals. David S. holds Bachelor'S Degree from University Of Delaware.

Profile bio

About David S.

Experienced DMPK scientist with extensive knowledge of drug metabolism pathways, drug metabolism assays (e.g., CYP450 inhibition), metabolite identification, and radiolabeled mass balance studies. Working knowledge of pharmacokinetics (Win-nonlin software) and human dose projection calculations.Management experience with direct report scientists (Ph.D. and B.A. level) and on two occasions I was in charge of the entire DMPK group.Project team representation for a number of projects in the cancer and immunology. Experience writing the DMPK section of the Investigator's Brochure, IND's and NDA's. For Rigel's SYK inhibitor Fostamatinib I answered DMPK questions that were raised by the reviewers in Europe and Canada to help get the drug approved in these countries. In addition, I worked with our Japanese colleagues at Kissei Pharmaceutical company to help get fostamatinib approved in Japan,

8 roles

David S. work experience

A career timeline built from the work history available for this profile.

Research Fellow

Vir Biotechnology Inc.

San Francisco Bay Area

Support the DMPK function by setting up the CYP450 inhibition assays, the microsomal metabolic stability assay, and metabolite identification for the small molecule projects. Summarized the data from a rat mass balance and profiling study for the SiRNa compound that is currently in clinical trials for hepatitis B and D.

Jan 2023 - Aug 2023

Dmpk Consultant

Vir Biotechnology And Rigel Pharmaceuticals

Started working at Rigel after I was let go, then picked up the work at Vir later in the year (June 2022)

Nov 2021 - Dec 2022

Research Fellow

Rigel Pharmaceutical

Was in charge of the drug metabolism section of the DMPK group. Worked on fostamatinib from when I started at Rigel to when it was approved and even beyond as I was in charge of the European environmental studies for fostamatinib. Worked on the rip1Kinase inhibitor R552 that is currently in Phase 2 clinical trials for Rheumatoid arthitis (Lilly).

Apr 2004 - Dec 2021

Senior Scientist

Sugen/ Pharmacia/Pfizer

South San Francisco, California, United States

Was responsible for the drug metabolism function within the DMPK group. Had up to 3 Ph.D. direct reports and one BA level scientist. We ran the standard drug metabolism assays, but also had in house a TV101L assay which was used to screen compound CYP1A induction. This was a big problem as many of the compounds were CYP1A substrates, so the autoinduction.

Jan 2000 - Dec 2003

Research Scienist

Gilead Sciences

Foster City, California, United States

Drug metabolism studies for Tamiflu, Adefovir and Tenofovir

Aug 1996 - Sep 2000

Research Investigator

North Chicago, Illinois, United States

Was the first person at Abbott to use hepatic microsomes for drug metabolism studies. Would prepare my own microsomes from human, rat, monkey and mouse. Set up a glucuronidation assay that was used to find 5-lipoxygenase inhibitors with better PK. Prepare and purify metabolites for NMR analysis.

Dec 1989 - Aug 1996

Research Investigator/Instructor

Birmingham, Alabama, United States

Studied the metabolism of the anticancer agent 5-FU. Identified the major biliary metabolites of 5-FU as conjugates of the 5-FU metabolite fluoro-beta alanine and the bile acids cholic acid and chenodeoxycholic acid.

Aug 1986 - Dec 1989

Post Doctoral Fellow

Oklahoma City, Oklahoma, United States

Studied the effect of ethanol consumption on enzymes for glucuronidation (UDP-glucuronosyl transferase)

Feb 1985 - Aug 1986
3 education records

David S. education

Ph.D., Pharmacology And Toxicology

University Of Maryland At Baltimore
FAQ

Frequently asked questions about David S.

Quick answers generated from the profile data available on this page.

Where is David S. based?

David S. is based in San Francisco Bay Area, United States, United States.

What companies has David S. worked for?

David S. has worked for Vir Biotechnology Inc., Vir Biotechnology And Rigel Pharmaceuticals, Rigel Pharmaceutical, Sugen/ Pharmacia/Pfizer, and Gilead Sciences.

How can I contact David S.?

You can use AeroLeads to view verified contact signals for David S., including work email, phone, and LinkedIn data when available.

What schools did David S. attend?

David S. holds Bachelor'S Degree from University Of Delaware.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the David S. you were looking for.

View similar profiles